Personalized Infliximab Induction Strategy With Model-informed Dosing in Patients With Crohn's Disease
Clinical trial NCT04974099 · TERMINATED
Trial details
- NCT number
- NCT04974099
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-01
- Primary completion
- 2024-08-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.